DMT-2′O-MOE-rA(bz) Phosphoramidite

non-animal source (no BSE/TSE risk)

300

Proligo Reagents

≥99% (³¹P-NMR), ≥99.0% (reversed phase HPLC)

powder

≤0.1% single unspecified Impurity (reversed phase HPLC), ≤0.3% P(III) 100-169ppm (³¹P-NMR), ≤0.3 wt. % water content (Karl Fischer), ≤0.5% CET-H-Phosphonate (reversed phase HPLC), ≤0.5% DIPA-H-Phosphonate (reversed phase HPLC), ≤0.5% DMT-rA(bz)moe (reversed phase HPLC), ≤0.5% DMT-rA(bz)moe-Bz (reversed phase HPLC), ≤0.5% DMT-rA(bz)moe-amidate (reversed phase HPLC), ≤0.5% H-Phosphonat (reversed phase HPLC), ≤0.5% O3, O5-Bis-DMT-rA(bz)moe (reversed phase HPLC), ≤3 wt. % residual solvent content

white to off-white

conforms (UV/VIS Identity)

conforms to structure for H-NMR, conforms to structure for LC-MS

−20°C